EXHIBIT 31

 

CERTIFICATION PURSUANT TO SECTION 302

 

I, Gary Riccio, certify that:

 

1.       Ihave reviewed this Form 10-Q of BioPharma Manufacturing Solutions, Inc.

 

2.       Basedon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under which such statements were made, not misleading with respect tothe period covered by this report;

 

3.       Basedon my knowledge, the financial statements, and other financial information included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presentedin this report;

 

4.       Theregistrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure ontrols and procedures(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in ExchangeAct Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)       Designed such disclosure controlsand procedures,or caused such disclosure controls and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;

 

b)       Designed such internal control overfinancial reporting, or caused such internal control over financial reporting to be designed under our supervision, to providereasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for externalpurposes in accordance with generally accepted accounting principles;

 

c)       Evaluated the effectiveness of theregistrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this report based on such evaluations; and

 

d)       Disclosed in this report any changein the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter(the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likelyto materially affect, the registrant's internal control over financial reporting; and

 

 

5.       Theregistrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation, to the registrant's auditorsand the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

a)       All significant deficiencies andmaterial weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adverselyaffect the registrant's ability to record, process, summarize and report financial information; and

 

b)       Any fraud, whether or not material,that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.